Sergio Traversa - Chief Executive Officer, Director at Relmada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RLMD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sergio Traversa - trading volume in the past year for Relmada Therapeutics, Inc.

Holdings reported by Sergio Traversa for Relmada Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 244,024 $975 K $4.00 Jan 31, 2024 Direct
Stock Option (right to buy) 183,881 May 24, 2024 Direct Common Stock

Transactions reported by Sergio Traversa for Relmada Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership